A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes

Summary

This study is a multi-center, randomized, open-label, parallel, positive-controlled registered clinical study,to evaluate the efficacy and safety of insulin degludec injection developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Timeline

Start

2021-07-27

Primary completion

2025-12-31

Completion

2025-12-31

Drugs

Indications